SYGNIS' AX200 shows efficacy in stroke patients
Phase IIa results exceed expectations
18-Sep-2007 -
Wolf-Rüdiger Schäbitz, MD, principal investigator of the SYGNIS AXIS study, using AX200 for the treatment of acute ischemic stroke, presented an expert analysis of the Phase IIa results. AX200 was found to be safe and revealed efficacy in stroke patients. The in-depth analysis of the study data ...
clinical trials
Germany
magnetic resonance imaging